Treatment of Fingernail Onychomycosis with Efinaconazole 10% Solution in a Patient with Scleroderma: A Case Report. uri icon

Overview

abstract

  • INTRODUCTION: Oral antifungals are typically preferred over topicals for moderate to severe onychomycosis due to efficacy and shorter treatment courses. However, systemics are contraindicated or cautioned in patients with liver dysfunction and with some autoimmune diseases, and in those taking interacting medications. Efinaconazole 10% solution is a topical antifungal therapy, but application for fingernail onychomycosis has not been adequately studied. CASE PRESENTATION: We present a case of a 78-year-old female with scleroderma and moderate onychomycosis of the right 4th fingernail successfully treated with topical efinaconazole 10% solution. CONCLUSION: We review the literature on contraindications to oral antifungals for onychomycosis, precautions with terbinafine in patients with some autoimmune diseases, and topical onychomycosis therapies. Topical efinaconazole may represent an effective alternative for patients with fingernail onychomycosis who have contraindications to oral medications.

publication date

  • March 9, 2022

Identity

PubMed Central ID

  • PMC9274809

Scopus Document Identifier

  • 85127033941

Digital Object Identifier (DOI)

  • 10.1159/000522407

PubMed ID

  • 35979526

Additional Document Info

volume

  • 8

issue

  • 4